Skip to search formSkip to main contentSkip to account menu

tiplaxtinin

National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Indoleacetic Acids

Narrower (1)

PAI 039

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Inhibition of SERPINe1 reduces rhabdoviral infections in zebrafish
2014
2014
Cell Cycle and Senescence PAI-1 Leads to G 1-Phase Cell-Cycle Progression through Cyclin D 3 / cdk 4 / 6 Upregulation
The canonical function of plasminogen activator inhibitor-1 (PAI-1/SERPINE1) is as an inhibitor of urokinasetype plasminogen… 
2013
2013
Small Molecule Therapeutics Targeting Plasminogen Activator Inhibitor-1 Inhibits Angiogenesis and Tumor Growth in a Human Cancer Xenograft Model
Cancers of the urinary bladder result in aggressive and highly angiogenic tumors for which standard treatments have only limited… 
2012
2012
Abstract 15151: Novel Tiplaxtinin Eluting Stent Inhibits the Migration of Vascular Smooth Muscle Cells but not Endothelial Cells
Introduction: Plasminogen activator inhibitor-1 (PAI-1), a key regulator of the plasminogen activator system and fibrinolysis… 
2011
2011
Inhibition of Plasminogen Activator Inhibitor-1 Expression in Smoke-Exposed Alveolar Type II Epithelial Cells Attenuates Epithelial-Mesenchymal Transition
Background: Smoking is a risk factor for idiopathic pulmonary fibrosis (IPF), but the mechanism of the association remains… 
2011
2011
Discovery of inhibitors of plasminogen activator inhibitor-1: structure-activity study of 5-nitro-2-phenoxybenzoic acid derivatives.
2008
2008
S35225 is a direct inhibitor of Plasminogen Activator Inhibitor type-1 activity in the blood.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)